Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination

Affiliations

¹ Department of Pediatrics, Hôpital René Dubos, Pontoise, France.
² Internal Medicine Department, French National Sickle Cell Referral Center, Hôpital Européen Georges Pompidou, Paris, France.
³ Paediatric Center for Sickle Cell Disease, Maison de la Femme de la Mère et de l'Enfant, Fort de France, France.
⁴ Department of General Pediatrics, Center for Sickle Cell Disease, Trousseau Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
⁵ Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
⁶ Department of Paediatric Hemato-oncology, University Hospital of Rennes, Rennes, France.
⁷ CH Sud Francilien, Corbeil-Essonnes, France.
⁸ Grand Hôpital de l'Est Francilien (GHEF), Meaux, France.
⁹ Referral Center for Sickle Cell Disease, Department of Pediatrics, Kremlin-Bicêtre Hospital, University Paris-Sud, Le Kremlin-Bicêtre, France.
¹⁰ CH Mayotte, Mamoudzou, France.
¹¹ Department of Pediatric Hematology, Bordeaux Hospital, Bordeaux, France.
¹² Institute of Paediatric Hematology and Oncology, Hospices Civils de Lyon, Lyon, France.
¹³ Faculty of medicine, Université de Paris Cité, Paris, France.

Stéphanie Eyssette-Guerreau et al. Br J Haematol. 2022 Oct.

. 2022 Oct;199(2):e8-e11.

doi: 10.1111/bjh.18409. Epub 2022 Aug 22.

¹ Department of Pediatrics, Hôpital René Dubos, Pontoise, France.
² Internal Medicine Department, French National Sickle Cell Referral Center, Hôpital Européen Georges Pompidou, Paris, France.
³ Paediatric Center for Sickle Cell Disease, Maison de la Femme de la Mère et de l'Enfant, Fort de France, France.
⁴ Department of General Pediatrics, Center for Sickle Cell Disease, Trousseau Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
⁵ Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
⁶ Department of Paediatric Hemato-oncology, University Hospital of Rennes, Rennes, France.
⁷ CH Sud Francilien, Corbeil-Essonnes, France.
⁸ Grand Hôpital de l'Est Francilien (GHEF), Meaux, France.
⁹ Referral Center for Sickle Cell Disease, Department of Pediatrics, Kremlin-Bicêtre Hospital, University Paris-Sud, Le Kremlin-Bicêtre, France.
¹⁰ CH Mayotte, Mamoudzou, France.
¹¹ Department of Pediatric Hematology, Bordeaux Hospital, Bordeaux, France.
¹² Institute of Paediatric Hematology and Oncology, Hospices Civils de Lyon, Lyon, France.
¹³ Faculty of medicine, Université de Paris Cité, Paris, France.

No abstract available

Conflict of interest statement

All authors declare no conflict of interest.

1. Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, et al. Risk factors for severe COVID‐19 in hospitalized sickle cell disease patients: a study of 319 patients in France. Am J Hematol. 2022;97(3):E86–91. - PMC - PubMed
1. Taytard J, Prevost B, Corvol H. More on BNT162b2 Covid‐19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(12):1191–2. - PubMed
1. Lauring AS, Tenforde MW, Chappell JD, Gaglani M, Ginde AA, McNeal T, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid‐19 from omicron, delta, and alpha SARS‐CoV‐2 variants in the United States: prospective observational study. BMJ. 2022;376:e069761. - PMC - PubMed
1. Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of omicron. MedRxiv [Preprint]. 2022; 2021.12.30.21268495. 10.1101/2021.12.30.21268495 - DOI
1. Martin B, DeWitt PE, Russell S, Sanchez‐Pinto LN, Haendel MA, Moffitt R, et al. Acute upper airway disease in children with the omicron (B.1.1.529) variant of SARS‐CoV‐2‐a report from the US national COVID cohort collaborative. JAMA Pediatr. 2022;176:819–21. - PMC - PubMed